Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Redwood City, CA
SEC filing record 1 source field available
Fiscal year end
31 December
SOLENO THERAPEUTICS INC has filed 1,135 SEC EDGAR filings since 24 Feb 2010

SEC filing history

Showing 801-825 of 1,000 matching filings.

Per page
25
Current page
33
4

FORM 4 SUBMISSION

Filing date
13 Apr 2017
Reporting date
07 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Apr 2017
Reporting date
07 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36593

DEF 14A

Filing date
13 Apr 2017
Reporting date
08 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-36593

8-K/A

Filing date
10 Apr 2017
Reporting date
06 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-36593

PRE 14A

Filing date
29 Mar 2017
Reporting date
08 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-215856

424B3

Filing date
21 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Mar 2017
Reporting date
07 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
21 Mar 2017
Reporting date
07 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Mar 2017
Reporting date
07 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Mar 2017
Reporting date
07 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-88637

SC 13D

Filing date
13 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Mar 2017
Reporting date
07 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Mar 2017
Reporting date
07 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
10 Mar 2017
Reporting date
07 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
10 Mar 2017
Reporting date
07 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Mar 2017
Reporting date
07 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Mar 2017
Reporting date
07 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
09 Mar 2017
Reporting date
07 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-215856

FILED PURSUANT TO RULE 424(B)(3) AND RULE 424(C)

Filing date
09 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36593

FORM 8-K

Filing date
08 Mar 2017
Reporting date
06 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-215856

FILED PURSUANT TO RULE 424(B)(3) AND RULE 424(C)

Filing date
01 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36593

FORM 8-K

Filing date
28 Feb 2017
Reporting date
28 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36593

FORM 8-K

Filing date
28 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-215856

FILED PURSUANT TO RULE 424(B)(3)

Filing date
27 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .